An expert panel of India’s Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech’s Covaxin for children in the 2 to 18 years age group with certain conditions,...

Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age and is expected to submit the data by next week to the DCGI, Chairman and...

As per WHO, the Strategic Advisory Group of Experts on Immunization (SAGE) will be meeting on October 5 to granting EUA to Covaxin

The World Health Organization’s approval for the indigenous COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to come this month, official sources said Monday.

The Union Health Minister Mansukh Mandaviya on Sunday released the first commercial batch of Covaxin from the new plant of Bharat Biotech at Ankleshwar in Gujarat's Bharuch district.

A single-dose of Covaxin provides a similar immunity response in previously Covid-infected people as those without previous history of Covid infection with two doses of vaccine, says Indian Council of...

Prime Minister Narendra Modi hailed those behind the vaccination drive and also praised people getting inoculated.

Over two weeks have gone by since the Christian Medical College Hospital, Vellore, obtained permission from the Drugs Controller General of India (DGCI) to conduct trials to find out the effects of...

An expert panel set up by an institute under the Ministry of Home Affairs (MHA) has predicted that the third wave of COVID-19 can hit the country anytime between September and October and suggested...

There is a shortage of Covaxin in Tamil Nadu and about 4 lakh people in the State are yet to receive their second dose, said Health Minister Ma Subramanian on Monday.